Contact
searchSearch
HMP Global

Podcasts

Podcasts
David F. Dinges, MS, MA, PhD, on the Cognitive Effect of Sleep Medications After Emergent Awakenings
05/14/2019
In this podcast, David F. Dinges, MS, MA, PhD, talks about his latest research on the cognitive effects of 2 well-known and widely used sleep medications after emergent awakenings. This research was performed in NASA astronauts and personnel.
In this podcast, David F. Dinges, MS, MA, PhD, talks about his latest research on the cognitive effects of 2 well-known and widely used sleep medications after emergent awakenings. This research was performed in NASA astronauts and personnel.
In this podcast, David F....
05/14/2019
Neurology
Podcasts
Antje Bischof on Spinal Cord Atrophy in Relapsing MS
05/08/2019
Antje Bischof, from the University of California, San Fransisco, talks about her research "Accelerated Cord Atrophy Precedes Conversion to Secondary Progressive Disease in Relapsing Multiple Sclerosis," which she presented at ACTRIMS Forum...
Antje Bischof, from the University of California, San Fransisco, talks about her research "Accelerated Cord Atrophy Precedes Conversion to Secondary Progressive Disease in Relapsing Multiple Sclerosis," which she presented at ACTRIMS Forum...
Antje Bischof, from the...
05/08/2019
Neurology
Podcasts
Pavan Bhargava, MD, on Metabolomic Profiling in MS Patients
04/23/2019
Pavan Bhargava, MD, discusses his latest research on metabolomic profiling in patients with multiple sclerosis, a topic in which he spoke about at ACTRIMS 2019 as well.
Pavan Bhargava, MD, discusses his latest research on metabolomic profiling in patients with multiple sclerosis, a topic in which he spoke about at ACTRIMS 2019 as well.
Pavan Bhargava, MD, discusses...
04/23/2019
Neurology
Podcasts
Joseph A. Diamond, MD, on Continuous Management of Sleep Disorders
04/22/2019
Joseph Diamond, MD, from the Icahn School of Medicine, answers the question at the end of Case Part 4 and discusses the management and treatment of sleep disorders and drug-drug interactions between other simultaneous medication use.
Joseph Diamond, MD, from the Icahn School of Medicine, answers the question at the end of Case Part 4 and discusses the management and treatment of sleep disorders and drug-drug interactions between other simultaneous medication use.
Joseph Diamond, MD, from the...
04/22/2019
Neurology
Podcasts
Madeline Fields, MD, on the Connection Between Epilepsy and Autism
04/09/2019
Children with autism are more likely to have epilepsy, and vice versa. Madeline Fields, MD, from Mount Sinai Hospital, answers our questions about this connection.
Children with autism are more likely to have epilepsy, and vice versa. Madeline Fields, MD, from Mount Sinai Hospital, answers our questions about this connection.
Children with autism are more...
04/09/2019
Neurology
Podcasts
Joseph A. Diamond, MD, on At-Home vs In-Lab Polysomnography for Sleep Disordered Breathing
04/08/2019
Joseph Diamond, MD, from the Icahn School of Medicine, answers the question at the end of Case Part 3 and discusses the difference between at-home vs in-lab polysomnography testing for sleep disordered breathing.
Joseph Diamond, MD, from the Icahn School of Medicine, answers the question at the end of Case Part 3 and discusses the difference between at-home vs in-lab polysomnography testing for sleep disordered breathing.
Joseph Diamond, MD, from the...
04/08/2019
Neurology
Podcasts
Joseph A. Diamond, MD, on Starting the Conversation About Sleep Disordered Breathing
03/25/2019
Joseph Diamond, MD, from the Icahn School of Medicine, answers the question at the end of Case Part 2 and explains how to start the conversation with your patients about sleep disordered breathing.
Joseph Diamond, MD, from the Icahn School of Medicine, answers the question at the end of Case Part 2 and explains how to start the conversation with your patients about sleep disordered breathing.
Joseph Diamond, MD, from the...
03/25/2019
Neurology
Podcasts
Joseph A. Diamond, MD, on Diagnosing Multiple Sleep Conditions
03/11/2019
Joseph Diamond, MD, from the Icahn School of Medicine, answers the question at the end of Case #1 and explains how to diagnose multiple comorbid sleep conditions.
Joseph Diamond, MD, from the Icahn School of Medicine, answers the question at the end of Case #1 and explains how to diagnose multiple comorbid sleep conditions.
Joseph Diamond, MD, from the...
03/11/2019
Neurology
Podcasts
Holistic Care for Neuropsychiatric Symptoms and Neurodegenerative Disease: Perspectives From a Nurse Practitioner
03/02/2019
In this podcast, Neurology Learning Network's Huntington Disease Section Editor Daniel Claassen, MD, interviews Jessie Gibson, PhD, RN, AGPCNP-BC, about the increasing role of nurse practitioners in managing patients with complex...
In this podcast, Neurology Learning Network's Huntington Disease Section Editor Daniel Claassen, MD, interviews Jessie Gibson, PhD, RN, AGPCNP-BC, about the increasing role of nurse practitioners in managing patients with complex...
In this podcast, Neurology...
03/02/2019
Neurology
Podcasts
Dr David Llewellyn on the Bias in Cognitive Assessments
02/04/2019
Dr David Llewellyn from the University of Exeter Medical School answers our questions about his research on dementia misclassification when using brief cognitive assessments.
Dr David Llewellyn from the University of Exeter Medical School answers our questions about his research on dementia misclassification when using brief cognitive assessments.
Dr David Llewellyn from the...
02/04/2019
Neurology

News

a neurologist reviews a brain model with a patient
News
Daytime Sleepiness Linked With Predementia Syndrome in Older Adults
12/10/2024
Older adults with sleep-related daytime dysfunction, consisting of excessive sleepiness and lower enthusiasm, are at increased risk of developing a predementia syndrome called motoric cognitive risk syndrome, according to a study published in...
Older adults with sleep-related daytime dysfunction, consisting of excessive sleepiness and lower enthusiasm, are at increased risk of developing a predementia syndrome called motoric cognitive risk syndrome, according to a study published in...
Older adults with sleep-related...
12/10/2024
Neurology
Regular Physical Activity After Dementia Diagnosis May Lower Mortality Risk
News
Regular Physical Activity After Dementia Diagnosis May Lower Mortality Risk
11/21/2024
Regular physical activity (PA) following dementia diagnosis could lower the risk of all-cause mortality, according to results from a retrospective cohort study published in the British Journal of Sports Medicine.
Regular physical activity (PA) following dementia diagnosis could lower the risk of all-cause mortality, according to results from a retrospective cohort study published in the British Journal of Sports Medicine.
Regular physical activity (PA)...
11/21/2024
Psych Congress Network
neurology brain stress
News
Targeted Lucidity Reactivation May Help Ease Narcolepsy-Related Nightmares
11/18/2024
Results from a pilot study of patients with narcolepsy provide proof-of-concept evidence that a procedure called targeted lucidity reactivation can be adapted for narcolepsy-related nightmares.
Results from a pilot study of patients with narcolepsy provide proof-of-concept evidence that a procedure called targeted lucidity reactivation can be adapted for narcolepsy-related nightmares.
Results from a pilot study of...
11/18/2024
Neurology
A doctor examines a patient who has a head injury from soccer
News
Concussion With Depression Worsens Symptoms, Brain Connectivity
11/15/2024
The comorbidity of depression and sports-related concussion amplifies symptoms of both conditions, according to study findings published in Brain Research.
The comorbidity of depression and sports-related concussion amplifies symptoms of both conditions, according to study findings published in Brain Research.
The comorbidity of depression...
11/15/2024
Psych Congress Network
News
Risk of Cardiovascular Disease May be Easing in Patients With PsA
11/08/2024
Meta-regression showed a lower rate of incident cardiovascular disease in more recent data for patients with psoriatic arthritis, but not for patients with spondyloarthritis, researchers report.
Meta-regression showed a lower rate of incident cardiovascular disease in more recent data for patients with psoriatic arthritis, but not for patients with spondyloarthritis, researchers report.
Meta-regression showed a lower...
11/08/2024
Rheumatology & Arthritis
Semaglutide May Lower Risk of Alzheimer Disease in Patients With Type 2 Diabetes
News
Semaglutide May Lower Risk of Alzheimer Disease in Patients With Type 2 Diabetes
11/05/2024
Patients with type 2 diabetes and obesity prescribed semaglutide had a 40% to 70% lower risk of a first-time Alzheimer disease (AD) diagnosis compared with patients taking other antidiabetic medications, according to a study published in...
Patients with type 2 diabetes and obesity prescribed semaglutide had a 40% to 70% lower risk of a first-time Alzheimer disease (AD) diagnosis compared with patients taking other antidiabetic medications, according to a study published in...
Patients with type 2 diabetes...
11/05/2024
Psych Congress Network
Alone or Together, CBT and Modafinil Improve MS-Related Fatigue
News
Alone or Together, CBT and Modafinil Improve MS-Related Fatigue
11/01/2024
The wake-promoting drug modafinil, CBT, and a combination of both were associated with comparable, significant improvement in fatigue at 12 weeks in patients with MS and problematic fatigue.
The wake-promoting drug modafinil, CBT, and a combination of both were associated with comparable, significant improvement in fatigue at 12 weeks in patients with MS and problematic fatigue.
The wake-promoting drug...
11/01/2024
Neurology
Gene therapy
News
Concerns Linger After Gene Therapy Shows Long-Term Benefit for Cerebral Adrenoleukodystrophy
10/28/2024
Elivaldogene autotemcel (eli-cel) gene therapy for cerebral adrenoleukodystrophy (CALD) helped patients maintain neurological function, but also my have caused hematologic malignancies in some patients.
Elivaldogene autotemcel (eli-cel) gene therapy for cerebral adrenoleukodystrophy (CALD) helped patients maintain neurological function, but also my have caused hematologic malignancies in some patients.
Elivaldogene autotemcel...
10/28/2024
Neurology
Patient with family
News
During Recovery, Stroke Patients Benefit from Supportive Social Networks
10/24/2024
Large networks of family and friends are beneficial for blood pressure improvement among patients who experienced a stroke, according to a study published online in the International Journal of Cerebrovascular Disease and Stroke. “In aging...
Large networks of family and friends are beneficial for blood pressure improvement among patients who experienced a stroke, according to a study published online in the International Journal of Cerebrovascular Disease and Stroke. “In aging...
Large networks of family and...
10/24/2024
Neurology
International Stroke Burden Saw Hike Over Last 30 Years
News
International Stroke Burden Saw Hike Over Last 30 Years
10/22/2024
International stroke burden has increased from 1990 to 2021, according to recent findings from a global burden of disease (GBD) study published in The Lancet Neurology.
International stroke burden has increased from 1990 to 2021, according to recent findings from a global burden of disease (GBD) study published in The Lancet Neurology.
International stroke burden has...
10/22/2024
Neurology

Alzheimer's Disease CME Series

Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources To view accreditation information/faculty disclosures for the program, click 
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources To view accreditation information/faculty disclosures for the program, click 
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesOnline Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesOnline Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click...
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click...
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data Online Form - PBHLN-NLN Alzheimers Video Series
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data Online Form - PBHLN-NLN Alzheimers Video Series
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety DataTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation...
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety DataTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation...
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action
11/12/2020
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early...
11/12/2020
Neurology
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology
11/12/2020
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology Online Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology Online Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease...
11/12/2020
Neurology
Claim-Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action
11/12/2020
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of ActionTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation button...
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of ActionTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation button...
Emerging Treatments for Early...
11/12/2020
Neurology
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease
11/10/2020
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease To view accreditation information/faculty disclosures for the program, click 
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease To view accreditation information/faculty disclosures for the program, click 
Current Treatment Limitations...
11/10/2020
Neurology

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use